Beverly L. Davidson, PhD, is Director of the Raymond G. Perelman Center for Cellular and Molecular Therapeutics and Chief Scientific Strategy Officer at Children’s Hospital of Philadelphia, where she holds the Arthur V. Meigs Chair in Pediatrics. She is also a Professor in the Department of Pathology and Laboratory Medicine at the Perelman School of Medicine at the University of Pennsylvania and a Co-Founder of Spark Therapeutics, Inc., a biotechnology company CHOP created in 2013 to accelerate the timeline for bringing new gene therapies to market.

Beverly L. Davidson completed her PhD in Biological Chemistry, and Postdoctoral Fellowship from the University of Michigan, Ann Arbor, MI. Her research is focused on the development of novel therapies to treat inherited brain disorders. Dr. Davidson’s main research interest includes lysosomal storage diseases, mucopolysaccharidoses, spinal cerebellar ataxia, understanding how noncoding RNAs participate in neural development and neurodegenerative diseases processes, etc.

Representative Publications:

Overcoming Limitations Inherent in Sulfamidase to Improve Mucopolysaccharidosis IIIA Gene Therapy

Share

Discuss in Social Wall

Share to rareTeam

Bookmark